Ganesh Benzoplast Ltd. (GANESHBE) — Tipsheet

NCLAT dismisses insolvency appeal, Ganesh Benzoplast wins legal fight

Tipsheet Editorial — Thu, 16 Jul 2026 16:53:43 GMT

The appellate tribunal closed a case that sought to drag the chemical firm into insolvency over a subsidiary's guarantee. The dispute is over with no penalty.

What’s new

NCLAT dismissed Progfin's appeal to start insolvency against Ganesh Benzoplast.
The original NCLT petition was rejected in September 2025; the appeal has now failed too.
Case closed without any penalty, removing a legal overhang for the micro-cap.

Why it matters

A corporate insolvency process could have disrupted operations and governance. With the NCLAT ruling, the company removes a contingent risk that weighed on sentiment, especially after strong FY26 profit growth of 93%.

What we’re watching

Whether the company resumes its margin recovery after the earlier guidance cut.
Any impact on credit lines or client relationships from the now-resolved dispute.

The full read

Ganesh Benzoplast has won a legal battle that threatened its very existence. The National Company Law Appellate Tribunal dismissed an insolvency appeal from Progfin, which had tried to drag the chemical firm into corporate insolvency over a subsidiary's guarantee. The NCLAT order, received July 15, follows the NCLT's own rejection in September 2025 — and closes the case with zero penalty. Hardly surprising. For a company with a market cap of just ₹746 crore, a corporate insolvency process could have been devastating, even if the risk was low. The ruling removes a legal overhang just as Ganesh Benzoplast reports a 93% surge in FY26 net profit to ₹733.4 million. The next test: whether it can rebuild margins after the earlier guidance cut on higher JNPT lease costs.

Primary source: BSE · NSE

Ganesh Benzoplast cuts margin guidance, flags higher JNPT lease costs

Tipsheet Editorial — Mon, 08 Jun 2026 15:22:34 GMT

On its annual concall, the micro-cap storage firm guided EBITDA margins on new capacity to 80%, down from 90%, and disclosed a ₹25 crore annual lease cost, 25% above its prior estimate.

What’s new

JNPT lease rental reset locked in at ₹25 crore annually, exceeding the ₹18-20 crore guidance.
EBITDA margin on new tank capacity guided down to 80% from 90%; rental margin revised to 45-47% from 50-55%.
Consolidated net profit rose 93% to ₹733 million for FY26, but guidance was weaker.

Why it matters

A 25% cost overrun on a core lease and simultaneous margin downgrades narrow the earnings upside from Ganesh Benzoplast's expansion. For a company growing profit 93% year-on-year, the guidance cuts suggest the next phase will be less profitable than planned. The market now has to recalibrate its model for the ₹100 crore JNPT expansion.

What we’re watching

Whether the higher lease cost persists or is a one-time adjustment.
Execution of the first 50,000 KL capacity phase by December 2025.
How the 15% chemical division growth holds up without exceptional items.

The full read

Ganesh Benzoplast delivered a strong year. Net profit rose 93% to ₹733 million in FY26. But the concall reset expectations for what comes next. The JNPT lease rental is now fixed at ₹25 crore annually, a 25% overshoot from the ₹18-20 crore guidance. Simultaneously, EBITDA margins on the new tank capacity being built with a ₹100 crore capex were guided down to 80% from 90%. The rental business margin itself was revised to 45-47% from 50-55%. The company is adding 110,000 KL at JNPT in two phases, with the first 50,000 KL due by December 2025. The chemical division grew about 15% year-on-year on an underlying basis. The good year is in the books. The guidance cuts tell a different story about the next one.

Primary source: BSE · NSE

Ganesh Benzoplast profit surges 93%. It's opening a Singapore outpost.

Tipsheet Editorial — Wed, 27 May 2026 15:44:47 GMT

The logistics and EPC firm's full-year net profit jumped to ₹733 million, and its board just greenlit a wholly owned subsidiary in Singapore to chase new business.

What’s new

Consolidated net profit jumped 93% to ₹733.4 million on revenue of ₹4.11 billion.
Board approved forming a wholly owned subsidiary in Singapore, pending regulatory approvals.
The LST division (EPC and wharfage) revenue rose to ₹2,389.1 million from ₹2,004.8 million.

Why it matters

A 93% profit jump is the headline. But for a micro-cap, the Singapore subsidiary is the more interesting signal. It's a bet on regional expansion that goes beyond the backward-looking results. The clean audit opinion leaves no governance drag.

What we’re watching

Whether Singapore regulatory approvals are secured and what business the subsidiary pursues.
Whether the strong profit growth sustains into Q1 FY27.
How the LST division's margin profile shapes the consolidated picture.

The full read

Ganesh Benzoplast's full-year results are strong. Consolidated net profit jumped 93% to ₹733.4 million on revenue of ₹4.11 billion. Standalone profit doubled to ₹613.29 million. The core growth driver was the LST division (EPC and wharfage services), which posted revenue of ₹2,389.1 million, up from ₹2,004.8 million and now representing about 58% of the consolidated top line. The auditors gave it a clean opinion. But the bigger move is strategic. The board just approved a wholly owned subsidiary in Singapore, still pending approvals, to chase new business in the region. For a micro-cap, that's a meaningful expansion push. It's the opposite of a routine earnings release.

Primary source: BSE · NSE